Navigation Links
Aflac Incorporated to Accelerate Share Repurchase in 2008; Authorizes Additional Share Repurchase and Increases Quarterly Cash Dividend 17.1%
Date:1/29/2008

COLUMBUS, Ga., Jan. 29 /PRNewswire-FirstCall/ -- Aflac Incorporated (NYSE: AFL) announced today that it intends on conducting an accelerated repurchase of approximately 12 million shares of its common stock in the first quarter of 2008. This accelerated share repurchase will be funded with internal capital.

(Logo: http://www.newscom.com/cgi-bin/prnh/20041202/CLTH019LOGO )

To provide for future share repurchase activities, the board of directors today authorized the purchase of up to an additional 30 million shares of its common stock. This authorization is in addition to the 25.6 million shares that remained under a previous authorization as of December 31, 2007, bringing the total number of shares available for purchase to 55.6 million.

The board of directors also approved a 17.1% increase in the quarterly cash dividend, effective with the first quarter payment. The first quarter dividend of $.24 per share is payable on March 3, 2008, to shareholders of record at the close of business on February 20, 2008.

Commenting on the news, Chairman and Chief Executive Officer Daniel P. Amos stated: "I am very pleased with today's actions by our board of directors. These steps are consistent with our intention of deploying excess capital in a manner that benefits our shareholders, while still maintaining very strong capital adequacy ratios to support our ratings.

"In addition to accelerating our planned annual repurchase of 12 million shares, we also anticipate buying more shares later in the year, depending on market conditions. Purchasing 12 to 18 million shares this year gives us greater confidence in achieving the high end of o
'/>"/>

SOURCE Aflac Incorporated
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine news :

1. Aflac Announces Resignation of U.S. Marketing Officer
2. Aflac Incorporated to Release Third Quarter Results On October 23, 2007
3. Aflac Incorporated Announces Third Quarter Results, Declares Fourth Quarter Cash Dividend
4. Aflac Honors Hispanic Entrepreneurs Making a Difference in Texas
5. Aflac Japan To Offer Cancer Insurance Product Through Japan Post
6. Aflac Incorporated to Present at the Goldman Sachs Financial Services CEO Conference 2007
7. Aflac to Sponsor Iron Girl
8. Accuray Incorporateds CEO to Speak at UBS Global Life Sciences Conference
9. Accuray Incorporated to Report First Quarter Fiscal Year 2008 Financial Results
10. Accuray Incorporated to Host Investor and Analyst Meeting at ASTRO 2007
11. ViroPharma Incorporated Reports Third Quarter and Nine-Month 2007 Financial Results

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2009)...t manufacturers who use medical load cells at the ...lars by bringing in technology partner Flintec ear...o-active medical manufacturers are calling in Flin...r projects, ensuring that progress will not be con...ly outdated technology. , ...
(Date:11/26/2009)...athiomolybdate (TM) has been shown in studies to b...disease caused by an overload of copper, and certa...ttle, however, is known about how the drug works a...hwestern University researchers now has provided a... of TM bound to copper-loaded metallochaperones. T...
(Date:11/26/2009)...Triangle Dental (RTDental), a leading dental group...ed the expansion of its services to include LUMINE...illan. , Durham, NC (P...nounce that Dr. Doug Macmillan, an experienced LU... advanced training seminar. RTDental’s abil...
(Date:11/25/2009)...ov. 25 Onyx Pharmaceut...the company will host two investor events in Decem...009 - 9:00 a.m. CT/10:00 a.m. ET ,, Principal...rounding carfilzomib in relapsed and/or refractory...n Society of Hematology (ASH) Annual Meeting and E...
(Date:11/25/2009)... The Black AIDS Institut...ermine executive leadership for 2010. ,, The ne...ers with specialties in public policy, law, financ...ness entrepreneurship. The Board also comes from a... heterosexual and gay Black men and women, some li...
Breaking Medicine News(10 mins):Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 2Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 4Health News:Research sheds light on workings of anti-cancer drug 2Health News:Research sheds light on workings of anti-cancer drug 3Health News:Dr. Douglas Macmillan Now Providing LUMINEERS at Research Triangle Dental 2Health News:Onyx Pharmaceuticals Announces December 2009 Investor Events 2Health News:Black AIDS Institute Announces 2010 Board Election Results 2
...nth of illegal abortions, said she will not contes...uth Wales (NSW) Medical// Tribunal. Suman So..., according to the Sydney Morning Herald newspaper...ounsel Mr Phillip Boulten and Mr Michael Fordham's...
...en’s Research Hospital has announced that improvem...r medulloblastoma have// significantly increased t... The treatment increased the overall five-ye... the 48 high-risk patients from 55 percent to 70 p...
People who have a low response to alcohol or the so called ability to
...may no longer be included in the specialist catego...omes into force//. A few radiologists who h...sicians understand the benefits of having them as ...st clinics. And the few who do get in just have to...
...a and dengue fever in the state has been brought o...s aegypti, mosquito is the common carrier of both .... Hence, the state has taken up an integrated mosq.... Padmanabhan, Director of Public Health and Preve...
... proteins in the eye is the main trigger for the u...searchers at Case Western Reserve University and t...lled blood vessel growth is one of the main reason... Salomon and his graduate students Kutralanathan R...
Other Medicine News:Health News:Improved Treatment Raises Medulloblastoma Survival Rate 2Health News:Molecule responsible for age associated macular degeneration identified 2
(Date:11/25/2009)...PRNewswire/ -- According to Millennium Research Gr...ogy market intelligence, the nearly $3 billion US ...o see rapid growth over the next five years despit...for Trauma Devices 2010 report finds that this ...ve years, with competitors introducing specialized...
(Date:11/25/2009)...nd JOHANNESBURG, November 25 ,iThem...covery announced today,that they have signed a col...ies, services. , Pyxis,s world class comp...ill be coupled with iThemba,s service division to ...to projects identified through Pyxis,internationa...
(Date:11/24/2009)...wire-FirstCall/ -- Endologix, Inc. (Nasdaq: ELGX ...aortic disorders, announced today that it has file... in, the patent infringement lawsuit brought again...s filed in the United States District Court in Ind...that the stay remain in effect while the United St...
Breaking Medicine Technology:US Trauma Fixation Device Market Not Seeing Signs of Slowdown 2US Trauma Fixation Device Market Not Seeing Signs of Slowdown 3iThemba Pharmaceuticals (Pty) Ltd and Pyxis Discovery B.V. Announce Collaborative Agreement to Offer a Combined Service Offering 2Endologix Files Motion to Discontinue Court Proceedings Related to Alleged Patent Infringement 2First Catalog Cancer Biochip for Sequence Capture Now Available from febit 12991 1First Catalog Cancer Biochip for Sequence Capture Now Available from febit 12991 2Elsevier launches official version of BrainNavigator 51462 1Elsevier launches official version of BrainNavigator 51462 2Mystery E coli genes essential for survival of many species 9234 1Mystery E coli genes essential for survival of many species 9234 2
...INESS WIRE)--Mar 26, 2007 - Study results show,tha... (Lp-PLA2), a,cardiovascular-specific inflammatory...ead to heart attack and stroke, is,especially pred...metabolic syndrome--a serious medical condition th...s, which were presented yesterday,at the American ...
...ch 26, 2007 /PRNewswire/ -- Cleveland Clinic,resea...pite raising,high density lipoprotein cholesterol ...did not slow the progression of,plaque buildup in ...und probe. , Steven Nissen, M.D., Chairman of Card...nvestigator of this clinical trial, will,present t...
Other Medicine Technology:Study Presented at the ACC Shows Inflammatory Enzyme Lp-PLA2,Predicts Heart Disease Risk in Metabolic Syndrome Patients 2Study Presented at the ACC Shows Inflammatory Enzyme Lp-PLA2,Predicts Heart Disease Risk in Metabolic Syndrome Patients 3Cholesterol Drug Fails to Slow Progression of Coronary Disease,Cleveland Clinic Study Reports 2Cholesterol Drug Fails to Slow Progression of Coronary Disease,Cleveland Clinic Study Reports 3Cholesterol Drug Fails to Slow Progression of Coronary Disease,Cleveland Clinic Study Reports 4
...iratory Products, ,Westmed designs, manufacturers...nesthesia and Respiratory professionals. Our missi...nce the clinician's ability to deliver quality med...om line. , ,Our web site is designed with our cus...
...iratory Products, ,Westmed designs, manufacturers...nesthesia and Respiratory professionals. Our missi...nce the clinician's ability to deliver quality med...om line. , ,Our web site is designed with our cus...
...lizer achieves optimum lung penetration for maximu...ze range is 1.04-1.10 µ at 6-8 LPM. Latex-fr...t., ,As the world leader in airway management pro...rance of proven technology by offering top brands ...
...lizer achieves optimum lung penetration for maximu...ze range is 1.04-1.10 µ at 6-8 LPM. Latex-fr...t., ,As the world leader in airway management pro...rance of proven technology by offering top brands ...
Medicine Products: